SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2008-11-06
Filing Date Changed: 2008-11-13
Documents: 3

SEC Accession No.
0001193125-08-235296
Filing date: 2008-11-13
Accepted: 2008-11-13 17:11:14

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq	Type	Document	Size	Description
1	8-K	d8k.htm	13377	FORM 8-K
2	EX-99.1	dex991.htm	277384	PRESS RELEASE
3	GRAPHIC	g37580g75f52.jpg	4861	GRAPHIC

		0001193125-08-235296.txt	299789	Complete submission text file

Filer Information:

US ONCOLOGY INC (Filer) (0000943061)
IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26190 | Film No.: 081185816
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Assistant Director 1

Business Address
16825 NORTHCHASE DR
STE 1300
HOUSTON TX 77060
2818732674

Mailing Address

US Oncology Holdings, Inc. (Filer) (0001333191)
IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-126922 | Film No.: 081185815
SIC: 8060 Services-Hospitals

Assistant Director 1

Business Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060
(832) 601-8766

Mailing Address
16825 NORTHCHASE DRIVE, SUITE 1300
HOUSTON TX 77060